Skip to content

Multiple Myeloma in Combination with Daratumumab and Dexamethasone in Adult Patients Who Have Received At Least One Prior Therapy

Living with Multiple Myeloma in Combination with Daratumumab and Dexamethasone in Adult Patients Who Have Received At Least One Prior Therapy means managing a challenging set of symptoms. This page lists medicine types such as Pomalidomide that may be part of a wider care strategy. Products containing Pomalidomide feature in this group.

Pomalyst

Pomalidomide

4mg

Treats relapsed and refractory multiple myeloma by modulating the immune system and directly targeting tumour cells through cereblon binding, producing anti-proliferative, anti-angiogenic and immunomodulatory effects.

From$63.90/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.